CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer.

Nagoya A, Sada R, Kimura H, Yamamoto H, Morishita K, Miyoshi E, Morii E, Shintani Y, Kikuchi A

Open source

DOI
10.21037/tlcr-22-571
Published
2023 Mar 31
Container
Translational lung cancer research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tlcr-22-571,
  title = {CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer.},
  author = {Nagoya A and Sada R and Kimura H and Yamamoto H and Morishita K and Miyoshi E and Morii E and Shintani Y and Kikuchi A},
  year = {2023},
  journal = {Translational lung cancer research},
  doi = {10.21037/tlcr-22-571},
  url = {https://doi.org/10.21037/tlcr-22-571}
}

RIS

TY  - JOUR
TI  - CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer.
AU  - Nagoya A
AU  - Sada R
AU  - Kimura H
AU  - Yamamoto H
AU  - Morishita K
AU  - Miyoshi E
AU  - Morii E
AU  - Shintani Y
AU  - Kikuchi A
PY  - 2023
JO  - Translational lung cancer research
DO  - 10.21037/tlcr-22-571
UR  - https://doi.org/10.21037/tlcr-22-571
ER  - 

APA

A, N., R, S., H, K., H, Y., K, M., E, M., E, M., Y, S., & A, K. (2023). CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer.. Translational lung cancer research. https://doi.org/10.21037/tlcr-22-571

Source records